# ROCURONIUM BROMIDE
> **ANDA219260** · Abbreviated New Drug Application (Generic) · Sponsor: BAXTER HLTHCARE CORP · Approved 2026-09-18
## Drug
- **FDA Application Number:** ANDA219260
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ROCURONIUM BROMIDE
- **Generic name:** Rocuronium Bromide
- **Active ingredients:** ROCURONIUM BROMIDE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** BAXTER HLTHCARE CORP
- **First approval:** 2026-09-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219260)
---
*MORVS · CC0 1.0*